Effect of corosolic acid on postchallenge plasma glucose levels

Diabetes Res Clin Pract. 2006 Aug;73(2):174-7. doi: 10.1016/j.diabres.2006.01.010. Epub 2006 Mar 23.


Corosolic acid (CRA) is a substance extracted from Lagerstroemia speciosa L. and has been reported to have biological activities in in vitro and experimental animal studies. In this study, 31 subjects were orally administered 10mg CRA or a placebo, on different occasions, in a capsule 5min before the 75-g oral glucose tolerance test (OGTT) in a double-blind and cross-over design. Nineteen subjects had diabetes, seven had impaired glucose tolerance, one had impaired fasting glucose, and four had normal glucose tolerance according to the 1998 WHO criteria. There were no significant differences in plasma glucose levels before and 30min after the administration. CRA treatment subjects showed lower glucose levels from 60min until 120min and reached statistical significance at 90min. In this study, we have shown for the first time that CRA has a lowering effect on postchallenge plasma glucose levels in vivo in humans.

Publication types

  • Controlled Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blood Glucose / analysis
  • Blood Glucose / drug effects*
  • Diabetes Mellitus / drug therapy*
  • Fasting
  • Female
  • Glucose Intolerance / drug therapy*
  • Humans
  • Male
  • Triterpenes / administration & dosage*


  • Blood Glucose
  • Triterpenes
  • corosolic acid